A practical reference on thymosin alpha-1: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide, 28 residues | N-terminal fragment of prothymosin alpha |
| Molecular mass | About 3108 Da | Acetylated form |
| Isoelectric point | Near 4.2 | Acidic peptide |
| Appearance | White to off-white lyophilized powder | Common supplied form |
| Typical storage | -20 °C or below, dry | Solution stability is lower |
20世纪70年代，研究者从胸腺提取物中纯化出多种小肽，Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤，产量低且成分复杂。随着固相肽合成技术成熟，实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上，并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。
市售的胸腺素α1通常以冻干粉形式提供，溶解后用于注射。其氨基酸组成包括多个酸性残基，因此在中性pH下带负电荷。该肽可溶于水和生理盐水，但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度，溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。
胸腺素α1（thymosin alpha 1，Tα1）是一种由28个氨基酸组成的酸性肽，N端被乙酰化，分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离，属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守，提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置，并非表示亚型编号。它既存在于胸腺，也存在于脾脏和淋巴结等免疫组织。
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
=== Americas === The Americas were more highly influenced by the Doctrine of Signatures than China, India, or Africa, most likely because of their colonial history with Europe. The majority of insect use in medicine is associated with Central America and parts of South America, rather than North America, and most of it is based on the medical techniques of indigenous peoples. Currently, insect medicine is practiced much more rarely than in China, India, or Africa, though it is still relatively common in rural areas with large indigenous populations. Some examples to follow: Chapulines, or grasshoppers, are commonly consumed as a toasted regional dish in some parts of Mexico, but they are also used medicinally. They are said to serve as diuretic to treat kidney diseases, to reduce swelling, and to relieve the pain of intestinal disorders when they are consumed. However, there are some risks associated with consuming chapulines, as they are known to harbor nematodes which may be transmitted to humans upon consumption. Much like the termites of Africa, ants were sometimes used as medicinal devices by the indigenous peoples of Central America. The soldier cast of the Army ant would be collected and used as living sutures by Mayans. This involved agitating an ant and holding its mandibles up to the wound edges; when it bit down, the thorax and abdomen were removed, leaving the head holding the wound together. The ant's salivary gland secretions were reputed to have antibiotic properties.
Due to the wide array of options in the seafood marketplace, seafood is far more susceptible to mislabeling than terrestrial food. There are more than 1,700 species of seafood in the United States' consumer marketplace, 80–90% of which are imported and less than 1% of which are tested for fraud. However, more recent research into seafood imports and consumption patterns among consumers in the United States suggests that 35%–38% of seafood products are of domestic origin. consumption suggests Estimates of mislabelled seafood in the United States range from 33% in general up to 86% for particular species. Byzantine supply chains, frequent bycatch, brand naming, species substitution, and inaccurate ecolabels all contribute to confusion for the consumer. A 2013 study by Oceana found that one third of seafood sampled from the United States was incorrectly labeled. Snapper and tuna were particularly susceptible to mislabelling, and seafood substitution was the most common type of fraud. Another type of mislabelling is short-weighting, where practices such as overglasing or soaking can misleadingly increase the apparent weight of the fish. For supermarket shoppers, many seafood products are unrecognisable fillets. Without sophisticated DNA testing, there is no foolproof method to identify a fish species without their head, skin, and fins. This creates easy opportunities to substitute cheap products for expensive ones, a form of economic fraud. Beyond financial concerns, significant health risks arise from hidden pollutants and marine toxins in an already fraught marketplace.
The earliest approaches to modern bird study involved the collection of eggs, a practice known as oology. While collecting became a pastime for many amateurs, the labels associated with these early egg collections made them unreliable for the serious study of bird breeding. To preserve eggs, a tiny hole was made and the contents extracted. This technique became standard with the invention of the blow drill around 1830. Egg collection is no longer popular; however, historic museum collections have been of value in determining the effects of pesticides such as DDT on physiology. Museum bird collections continue to act as a resource for taxonomic studies.
2007 The book Ending Aging written by Aubrey de Grey and his research assistant Michael Rae. 2007 First evidence that a pharmacological agent (namely, metformin) at a certain dosage is capable to increase the lifespan of mice. 2008 Foundation of the Max Planck Institute for Biology of Ageing. 2008 (approximately) It was observed that different variants of FOXO3 gene are associated with human longevity. Since then, research has been conducted to better understand its functions and the mechanism of action. 2009 Association of genetic variants in insulin/IGF1 signaling with human longevity. 2009 A second pharmacological agent (namely, rapamycin) was shown to be capable to increase the lifespan of mice. For this discovery Dave Sharp receive a special prize from the Methuselah Foundation. 2009 The SENS Research Foundation, a research institute dedicated to studying the aging process and ways to reverse it based on the strategies for engineered negligible senescence approach, was established by Aubrey de Grey. 2010s first half The appearance of small political parties in different countries that make the promotion of anti-aging technologies part of their political platforms (for example, Science Party of Australia, U.S. Transhumanist Party, Party for Rejuvenation Research). 2010 Harvard University scientists at the Dana–Farber Cancer Institute partially reversed age-related degeneration in mice by engineering an improved telomerase gene. 2012 It was discovered that protein Sirtuin 6 (SIRT6) regulates the lifespan of male mice (but not female mice).
zinc finger (ZF) A supersecondary polypeptide structural motif and DNA-binding domain occurring in many DNA-binding proteins, characterized by a series of non-adjacent amino acid residues which fold into a three-dimensional arrangement capable of coordinating one or more zinc ions (Zn2+) between them, thus stabilizing the fold into a definite structure that can interact specifically with other biomolecules such as nucleic acids or other polypeptides. There are many distinct classes of zinc fingers using different ligands and spatial arrangements to achieve coordination; in perhaps the most common variant, a short alpha helix is oriented antiparallel to a β sheet, with two histidine residues in the former and two cysteines in the latter forming the coordination complex. Zinc fingers bind DNA as the primary functional domain of many transcription factors.
Sources: en.wikipedia.org
=== Davis Cup === Zverev made his Davis Cup debut for Germany against the Czech Republic in 2016. He faced No. 7 Tomáš Berdych in his debut match and took a two sets to one lead before ultimately losing in five sets. After the Czech Republic won the doubles rubber while Kohlschreiber won both singles matches, Zverev faced Lukáš Rosol in a decisive fifth rubber. Rosol won the match easily to send the Czech Republic into the next round. In the 2017 against Belgium, Zverev recorded his first career match win in the competition against Arthur De Greef, but lost the doubles rubber with his brother as well as his second singles match to Steve Darcis. Belgium won the tie 4–1. Zverev won his first Davis Cup tie in 2018, winning both of his singles matches against Alex de Minaur and Kyrgios to lead Germany to a 3–1 victory over Australia. In the quarterfinals, Germany took a 2–1 lead against Spain behind Zverev's win over David Ferrer and a victory in doubles. However, Spain ultimately won the tie on the final day after Zverev was unable to defeat Nadal and Kohlschreiber lost a tight five-set match to Ferrer. In 2019, the format of the Davis Cup was changed to have eighteen countries competing in the finals over a single week in November, all but six of which were decided through a qualifying round in February. Germany was placed in the qualifying round and drawn against Hungary. Zverev participated and won both of his singles matches as Germany won the tie 5–0. He did not participate in the finals in November, in which Germany lost in the quarterfinals.
==== Cossack autonomies in Don, Kuban and North Caucasus ==== Soon after the Bolsheviks seized power in Petrograd on 7–8 November 1917, most Cossack atamans and their government refused to recognize the legitimacy of the new regime. The Don Cossack ataman, Aleksey Kaledin, went as far as to invite opponents of the Bolsheviks to the Don Host. But the position of many Cossack governments was far from secure, even within the boundaries of their hosts. In some areas, soviets formed by outlanders and soldiers rivaled the Cossack government, and ethnic minorities also tried to acquire a measure of self-rule. Even the Cossack communities themselves were divided, as the atamans tended to represent the interests of prosperous landowners and the officer corps. Poorer Cossacks, and those serving in the army, were susceptible to Bolshevik propaganda promising to spare "toiling Cossacks" from land appropriation. The unwillingness of rank-and-file Cossacks to vigorously defend the Cossack government enabled the Red Army to occupy the vast majority of Cossack lands by late spring of 1918. But the Bolsheviks' policy of requisitioning grain and foodstuffs from the countryside to supply Russia's starving northern cities quickly fomented revolt among Cossack communities. These Cossack rebels elected new atamans and made common cause with other anticommunist forces, such as the Volunteer Army in South Russia. Subsequently, the Cossack homelands became bases for the White movement during the Russian Civil War.
=== Prevention of Oxidative Damage === Cellular defenses against the damaging effects of oxidative stress involve both enzymatic and nonenzymatic components. The enzymatic components may directly scavenge active oxygen species or may act by producing the nonenzymatic antioxidants. There are four enzymes that provide the bulk of protection against deleterious reactions involving active oxygen in bacteria: SODs (superoxide dismutases encoded by sodA and sodB), catalases (katE and katG), glutathione synthetase (gshAB) and glutathione reductase (gor). Some bacteria have NADH-dependent peroxidases specific for H2O2. The main nonenzymatic antioxidants in E. coli are GSH and thioredoxin (encoded by trxA). Ubiquinone and menaquinone may also serve as membrane-associated antioxidants.
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes preclinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug. The entire process—from concept through preclinical testing in the laboratory to clinical trial development, including Phase I–III trials—to approved vaccine or drug typically takes more than a decade.
Sources: en.wikipedia.org
It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.
Thymosin alpha-1 is a single defined 28-residue peptide, while the broader family includes unrelated peptides such as thymosin beta-4. The shared name reflects historical isolation from thymus tissue rather than a common structure. Confusion between the two is common in older literature.
No single pathway fully accounts for its reported effects. Several studies describe interaction with innate immune receptors and downstream cytokine changes, but the complete picture is not settled. Open questions remain about which effects occur at physiological concentrations.
It is usually described as an immunomodulatory peptide rather than a classic circulating hormone. No endocrine gland is known to release it as a primary secretory product, and its measured presence in blood is not firmly established.